Trial Details
COMPLETEDBasic Information
| Clinical ID | c3925 |
|---|---|
| Identifier | NCT01316601 |
| Trial Title | A Study to Assess Efficacy, Safety and Tolerability of the Anti-IL-13 Monoclonal Antibody QAX576 in the Treatment of Perinanal Fistulas in Patients Suffering From Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | DRUG: QAX567 |
Participant Information
| Sponsor | Gerhard Rogler |
|---|---|
| City | Zurich |
| Country/Region | Switzerland |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2011-01 |
|---|---|
| Primary Completion Date | 2012-11 |
| Completion Date | 2012-11 |